Table: Haba Laboratories Inc - 9-MTH group results
Feb 13 (Reuters)-
Haba Laboratories Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2025 Dec 31, 2024 Mar 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 8.72 8.61 12.55
(+1.3 pct) (-0.3 pct) (+4.0 pct)
Operating 513 mln 221 mln 500 mln
(+132.4 pct) (-15.2 pct)
Recurring 501 mln 236 mln 490 mln
(+112.5 pct) (-19.5 pct)
Net 318 mln 220 mln 480 mln
(+44.2 pct) (-16.7 pct)
EPS 84.24 yen 58.42 yen 126.93 yen
Ann Div 40.00 yen 40.00 yen
-Q2 div NIL NIL
-Q4 div 40.00 yen 40.00 yen
NOTE - Haba Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4925.T